High LDL cholesterol is one of the most well-established causes of heart disease. The evidence comes from three independent lines of research: studies of how LDL damages arteries at a cellular level, genetic analyses showing that people born with naturally higher LDL have shorter lifespans, and clinical trials demonstrating that lowering LDL reduces heart attacks. Each line of evidence points in the same direction, which is why major cardiology organizations treat the relationship as causal, not merely a correlation.
How LDL Damages Your Arteries
LDL particles carry cholesterol through your bloodstream. The problem starts when these particles slip through the inner lining of your artery walls, a process called subendothelial retention. Once trapped inside the artery wall, LDL particles become chemically modified through oxidation. Your immune system recognizes these oxidized particles as foreign invaders and sends white blood cells to consume them. Those white blood cells gorge on the oxidized LDL, swell into what pathologists call “foam cells,” and begin forming a fatty streak inside the artery.
Over years and decades, this process builds into a full plaque: a core of dead cells, oxidized fats, and debris surrounded by a fibrous cap. The plaque narrows the artery, restricting blood flow. More dangerously, that cap can rupture. When it does, the contents of the plaque trigger a blood clot that can block the artery entirely, causing a heart attack or stroke. This entire chain of events begins with LDL particles entering the artery wall. Without elevated LDL, the process either doesn’t start or progresses far more slowly.
Areas where blood flow is turbulent, like the branch points of arteries, are especially vulnerable. Turbulent flow weakens the protective lining of the vessel and makes it easier for LDL to infiltrate. This explains why plaques tend to form in predictable locations rather than uniformly throughout the circulatory system.
Genetic Evidence: A Natural Experiment
The strongest evidence that LDL causes heart disease (rather than simply appearing alongside it) comes from Mendelian randomization studies. These use natural genetic variation as a kind of lifelong experiment. Some people are born with gene variants that give them slightly higher or lower LDL levels from birth. Because these variants are assigned randomly at conception, they’re not tangled up with lifestyle factors like diet, exercise, or smoking.
A study published in the British Journal of Clinical Pharmacology found that a one-standard-deviation increase in genetically determined LDL was associated with 1.2 fewer years of life. People with genetically higher LDL had 28% lower odds of surviving to the 90th percentile of age compared to the 60th percentile. These findings held up across multiple statistical sensitivity checks and across different genes that influence LDL levels. The consistency is important: it doesn’t matter which gene raises your LDL. What matters is that it’s raised.
Lowering LDL Reduces Heart Attacks
A meta-analysis of 60 randomized controlled trials found that for every 1 mmol/L reduction in LDL (about 39 mg/dL), the risk of major cardiovascular events dropped by 22%. That’s a consistent, dose-dependent relationship: the more you lower LDL, the fewer heart attacks, strokes, and cardiovascular deaths occur. This holds true across different types of cholesterol-lowering treatments, reinforcing that it’s the LDL reduction itself doing the work, not some side benefit of a particular medication.
Not All LDL Particles Are Equal
Your standard cholesterol panel reports LDL-C, which measures the total amount of cholesterol carried by LDL particles. But the number of particles matters too, and particle size plays a role in risk. People who carry predominantly small, dense LDL particles (called pattern B) face roughly three times the risk of coronary artery disease compared to those with larger, more buoyant particles. This elevated risk persists even after accounting for total cholesterol and other standard markers.
This helps explain a frustrating clinical scenario: some people with “normal” LDL-C levels still develop heart disease. They may have a high number of small, dense particles that collectively carry a normal amount of cholesterol but do outsized damage because small particles penetrate artery walls more easily and are more prone to oxidation.
A more accurate way to assess this risk is through apolipoprotein B (apoB), a protein found on the surface of every LDL particle. Because each particle carries exactly one apoB molecule, measuring apoB effectively counts your LDL particles. A systematic review found that apoB outperformed LDL-C as a predictor of cardiovascular risk in every study that compared them directly (9 out of 9). If your doctor offers an apoB test, it gives a sharper picture of your actual risk than LDL-C alone.
When Other Risk Factors Amplify LDL’s Damage
High LDL doesn’t operate in isolation. Lipoprotein(a), often written as Lp(a), is a genetically determined particle similar to LDL that independently raises cardiovascular risk. When both Lp(a) and LDL are elevated, their effects multiply. Research on additive interactions found a significant synergistic effect between the two, with heart attack risk showing the strongest synergy. About 20% of people have elevated Lp(a) levels, and unlike LDL, Lp(a) is largely unaffected by diet or standard cholesterol medications. If you have high LDL, knowing your Lp(a) level helps clarify how aggressively it makes sense to manage your LDL.
Chronic inflammation also accelerates the process. When artery walls are already inflamed, LDL particles are trapped and oxidized more readily, and plaques are more likely to rupture. This is one reason why conditions like diabetes, obesity, and autoimmune diseases increase heart disease risk beyond what LDL levels alone would predict.
LDL Thresholds and What They Mean
Current guidelines don’t use a single cutoff to define “high” LDL. Instead, your target depends on your overall cardiovascular risk profile. For someone at low risk with no other major factors, keeping LDL below 130 mg/dL is generally considered adequate. For moderate-risk individuals, the target drops to 115 mg/dL. People at high risk, including those with diabetes or chronic kidney disease, are typically advised to aim below 100 mg/dL. Those at very high risk, such as people who have already had a heart attack, target below 70 mg/dL, and extremely high-risk patients may aim below 55 mg/dL.
An LDL level of 190 mg/dL or above is classified as severe hypercholesterolemia and is treated as a high-risk condition on its own, regardless of other factors. At this level, the sheer volume of LDL particles entering artery walls is enough to drive rapid plaque formation even in young, otherwise healthy people.
The Age Factor
The relationship between LDL and heart disease is clearest in adults under 75. In very elderly populations (85 and older), some observational data show that LDL loses its predictive power for overall mortality. A study of Chinese adults aged 85 and above found that higher LDL was not significantly associated with death from any cause. This likely reflects survivorship bias: people who reach very old age with high LDL may have protective factors that allowed them to survive despite it. It does not mean high LDL is safe at younger ages, when arterial damage accumulates over decades and leads to events in middle and later life.
In fact, the genetic evidence underscores that the total amount of LDL exposure over a lifetime is what matters most. Someone with moderately elevated LDL in their 30s and 40s accumulates arterial damage long before it shows up as symptoms. By the time chest pain or shortness of breath appears, the disease is often advanced. This is why LDL management earlier in life has a disproportionately large payoff compared to interventions that begin only after a first cardiac event.